This risk minimisation material has been developed for Eliquis for all indications. Please ensure that you are familiar with this material before prescribing Eliquis as it contains important safety information. In particular, it is aimed at increasing awareness about the potential risk of bleeding during treatment with Eliquis and providing guidance on how to manage that risk. If you would like a hard copy of the Eliquis Prescriber Guide and/or Patient Alert Cards and/or Summary of Product Characteristics (5mg and 2.5mg) posted out to you, please contact Bristol-Myers Squibb Medical Information (telephone: 0800 731 1736; e-mail: email@example.com) with your specific request. Please note that risk minimisation materials can only be delivered to UK registered healthcare premises.
For Healthcare Professionals